Stifel maintains Healwell AI buy rating and C$2.25 target
Baystreet reports Stifel maintains a Buy rating on Healwell AI Inc. and keeps its C$2.25/share price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.